USP5‐dependent HDAC1 promotes cisplatin resistance and the malignant progression of non–small cell lung cancer by regulating RILP acetylation levels
Abstract Background Non‐small cell lung cancer (NSCLC) is a leading cause of cancer‐related deaths worldwide, with cisplatin (DDP) resistance being a significant challenge in its treatment. Histone deacetylase 1 (HDAC1) has been implicated in the regulation of NSCLC progression; however, its role in...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2025-01-01
|
| Seri Bilgileri: | Thoracic Cancer |
| Konular: | |
| Online Erişim: | https://doi.org/10.1111/1759-7714.15478 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|